ArticleAntimicrobial agents and chemotherapy2007
Quinolone resistance in Helicobacter pylori isolates in Germany.
Article in Antimicrobial agents and chemotherapy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The efficacy of moxifloxacin-based triple therapy in treatment of Helicobacter pylori infection: a systematic review and meta-analysis of randomized clinical trials.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2013Pooled it
- Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy.Helicobacter · 2013Trial
- Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial.Annals of clinical microbiology and antimicrobials · 2010Trial
- Antibiotic Resistance ofMedicina (Kaunas, Lithuania) · 2022Article
- Revisiting Therapeutic Strategies forMolecules (Basel, Switzerland) · 2021Review
- Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients.Archives of medical research · 2021Article
- Unacceptable Antibiotic Resistance Rates for Helicobacter pylori in Turkey: Something Must Change.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2021Article
- Microarray-Based Detection and Clinical Evaluation forBioMed research international · 2018Article
- The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China.Medicine · 2016Article
- Article
- Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy.Gastroenterology research and practice · 2015Article
- Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.World journal of gastroenterology · 2014Review
- Helicobacter pylori resistance rates for levofloxacin, tetracycline and rifabutin among Irish isolates at a reference centre.Irish journal of medical science · 2013Article
- Antibiotics resistance rate of Helicobacter pylori in Bhutan.World journal of gastroenterology · 2013Article
- The incidence of primary antibiotic resistance of Helicobacter pylori in Vietnam.Journal of clinical gastroenterology · 2013Article
- Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.Annals of clinical microbiology and antimicrobials · 2013Article
- Molecular Detection of Antibiotic Resistance in South African Isolates of Helicobacter pylori.Gastroenterology research and practice · 2013Article
- Rescue Therapy for Helicobacter pylori Infection 2012.Gastroenterology research and practice · 2012Article
- Isolation of Helicobacter pylori in gastric mucosa and susceptibility to five antimicrobial drugs in Southern chile.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2011Article
- Should quinolones come first in Helicobacter pylori therapy?Therapeutic advances in gastroenterology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We show that quinolone resistance in Helicobacter pylori has reached an alarming level in Germany. Our data suggest that the use of quinolones requires prior antimicrobial susceptibility testing, especially for isolates from patients who have already undergone previous unsuccessful eradication treatments, and also underline the further need for surveillance studies to monitor antibiotic resistance in H. pylori.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.